NAMS
NewAmsterdam Pharma Company N.V. · Healthcare
Director Louis G Lange sold $1.4M of NewAmsterdam Pharma Company N.V.
Sold$1,357,230
$30.42Price
44,619Shares
−81%Stake
What NAMS did after the filing
- The stock from Thu, Mar 12 close, $29.82
- −0.3%
- S&P 500, same days
- +7.2%
Measured over 30 trading days, to the Apr 24 close.
Traded Wed, Mar 11. Filed Thu, Mar 12, 12:25 PM ET, during the session. Returns use the Mar 12 close and the Apr 24 close. Not investment advice.